<DOC>
	<DOC>NCT01241292</DOC>
	<brief_summary>The purpose of this study is to assess the safety and tolerability of Elotuzumab when given in combination with Lenalidomide and low-dose Dexamethasone in subjects with relapsed or refractory multiple myeloma (MM) in Japan.</brief_summary>
	<brief_title>Japanese Study of BMS-901608 (Elotuzumab) in Combination With Lenalidomide and Low Dose Dexamethasone</brief_title>
	<detailed_description />
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms, Plasma Cell</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>Lenalidomide</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>For additional information, please contact the BMS oncology clinical trial information service at 8552160126 or email MyCancerStudyConnect@emergingmed.com. Please visit www.BMSStudyConnect.com for more information on clinical trial participation. Received between 1 to 4 prior lines of therapy Measureable disease Men and women of childbearing potential (WOCBP) must be using two acceptable methods of contraception Men must agree to use a latex condom and a second form of birth control during sexual contact with WOCBP and must agree to not donate semen during study drug therapy Subjects must be willing to refrain from blood donations during study drug therapy Subjects with nonsecretory or oligosecretory or lightchain only myeloma or active/prior plasma cell leukemia or known /suspect POEMS syndrome Solitary bone or solitary extramedullary plasmacytoma as the only evidence of plasma cell dyscrasia Unable to take aspirin daily as prophylactic anticoagulation therapy. Prior history of inability to tolerate weekly 40 mg dexamethasone History of renal failure History of clinical significant thrombosis, such as treatment for thrombosis was required</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>